More recently, Xia and co-authors reported the discovery of a direct, co-factor-independent inhibitor of InhA, AN12855, which showed good efficacy in acute and chronic murine TB models that was also comparable to isoniazid (17, 18). This evidence concerns the gene INHA and tuberculosis.